Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma. | Mol Med | 2023 | 37848835 | PubTator, text mining | PubMed |
| Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer. | Front Oncol | 2023 | 37841442 | PubTator, text mining | PubMed |
| Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease. | Front Immunol | 2023 | 37841239 | PubTator, text mining | PubMed |
| Orbital SOX10-mutant schwannoma with plexiform growth: Expanding the histopathological spectrum of a new molecular group. | J Neuropathol Exp Neurol | 2023 | 37837311 | PubTator, text mining | PubMed |
| Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells. | Int J Mol Sci | 2023 | 37834227 | PubTator, text mining | PubMed |
| Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients. | Neurooncol Adv | 2023 | 37811539 | PubTator, text mining | PubMed |
| Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. | J Immunother Cancer | 2023 | 37802604 | PubTator, text mining | PubMed |
| Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition. | J Immunother Cancer | 2023 | 37802603 | PubTator, text mining | PubMed |
| α1,3-fucosylation of MEST promotes invasion potential of cytotrophoblast cells by activating translation initiation. | Cell Death Dis | 2023 | 37798282 | PubTator, text mining | PubMed |
| Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. | Nat Commun | 2023 | 37798266 | PubTator, text mining | PubMed |
| High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma. | Front Immunol | 2023 | 37781365 | PubTator, text mining | PubMed |
| The roles of FLOT1 in human diseases (Review). | Mol Med Rep | 2023 | 37772385 | PubTator, text mining | PubMed |
| A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors. | Clin Proteomics | 2023 | 37770851 | PubTator, text mining | PubMed |
| Portrait of Dysferlinopathy: Diagnosis and Development of Therapy. | J Clin Med | 2023 | 37762951 | PubTator, text mining | PubMed |
| Interaction of S100A6 Protein with the Four-Helical Cytokines. | Biomolecules | 2023 | 37759746 | PubTator, text mining | PubMed |
| Single-cell transcriptomics delineates the immune cell landscape in equine lower airways and reveals upregulation of FKBP5 in horses with asthma. | Sci Rep | 2023 | 37758813 | PubTator, text mining | PubMed |
| The pathology of oxidative stress-induced autophagy in a chronic rotator cuff enthesis tear. | Front Physiol | 2023 | 37753454 | PubTator, text mining | PubMed |
| Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE-Choroid. | Invest Ophthalmol Vis Sci | 2023 | 37750741 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways. | J Biol Chem | 2023 | 37739035 | PubTator, text mining | PubMed |
| Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications. | Cell Commun Signal | 2023 | 37735659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers?page=9